#None #Data Analytics #Xtalks #R Programming

Upcoming Webinar: R in Clinical Data Analytics

Data analytics in clinical trials has long been dominated by SAS, recognized as the industry standard for statistical programming and regulatory submissions. However, the landscape is changing with the emergence of new tools and methodologies, prompting organizations to explore alternatives. R, an open-source programming language, has gained traction as a robust option for clinical data analytics, and this upcoming webinar hosted by Xtalks aims to delve into this critical shift.

Why R Now?

Over recent years, there has been a significant evolution in how data analysis is approached in the clinical setting. Factors such as open-source innovation, AI integrations, and more cost-effective technology options have all contributed to this transformation. With its supportive community and a plethora of packages designed for various analytical purposes, R is increasingly viewed as a strategic choice for organizations seeking to modernize their data analytics frameworks.

Webinar Highlights

Scheduled for May 21, 2026, at 9 AM EDT, this free webinar will offer valuable insights into how R can facilitate a compliant and future-ready approach to clinical data analytics. Experts in the field will cover key topics, including governance strategies, validation techniques in compliance with GxP environments, and the operational factors influencing the shift from traditional platforms like SAS to R.

Key Discussion Points:

• - Technical Considerations: Attendees will hear about the advances in validation frameworks and package governance, ensuring that R can meet the stringent regulatory requirements typical in the pharmaceutical and biotech industries.
• - Real-World Adoption: The session will discuss how leading pharmaceutical companies are integrating R into their data science practices, including its role in AI-enabled workflows and modern data ecosystems.
• - Balancing Innovations with Compliance: Rather than focusing solely on a direct comparison between SAS and R, the discussion will provide a balanced perspective on creating future-ready statistical environments. The importance of compliance, validation, and audit readiness in regulated settings will be emphasized, along with how to future-proof analytics without compromising on innovation and efficiency.

Who Should Attend?

This webinar is particularly relevant for professionals in the pharmaceutical, biotech, and healthcare sectors, as well as those involved in clinical trials and data analytics. If you're seeking to understand the implications of adopting R in your organization’s data analytics strategy, this session is tailor-made for you.

Meet the Experts

Participants will have the opportunity to learn from a panel of distinguished speakers:

• - Tai Xie, PhD - CEO of CIMS Global
• - Peng Zhang, PhD - Associate Director of Innovative Data Sciences at CIMS Global
• - Daniel Sabanés Bové, PhD - Co-Founder of RPACT
• - Will Landau - Senior Advisor at Eli Lilly and Company
• - Joseph Rickert - R Community Champion

Conclusion

As the analytics environment rapidly evolves, staying informed on the tools and methodologies can greatly benefit organizations looking to not only ensure compliance but also drive innovation. Register now for this essential webinar to discover how R can support a compliant, future-ready approach to clinical data analytics.

To secure your spot for this enlightening session, visit Xtalks Registration today!

• ---